|
Dr
Nafo-Traoré,
Dr
Samba,
Ministers,
Colleagues,
It is a pleasure to attend this Global Alliance for
Vaccines and Immunization luncheon in Brazzaville; especially since
the Alliance is now up and running and making a difference in people’s
lives, in Africa and around the world.
For this we must thank the myriad of participants
who have selflessly given their time and energy in the creation,
implementation and running of GAVI. These include the board, the
working group, the secretariat and the wider network of GAVI partners
including national governments, research institutions, donors and the
partner agencies at the country level.
We know from experience that immunization is one of
the most cost-effective health interventions available. Access to
effective immunization saves lives and contributes to the well being
of all societies.
During the 1980s the proportion of the world's
children immunized with six antigens for common childhood illnesses
rose dramatically. But, during the 90s, some countries experienced
stagnation and some even had setbacks in their efforts to strengthen
their immunization programmes. In addition, the world's poorest and
most vulnerable people were not able to access the newer
cost-effective vaccines such as hepatitis B.
Two years ago we came together to respond to this
challenge - to contribute to poverty reduction and the well being of
disadvantaged societies. We looked for a better way to respond to the
needs of children and to increase their access to immunization.
I believe we have found one.
We brought together governments, private entities,
NGOs and UN agencies around the best available evidence.
We put countries at the centre of our work.
We mobilized new investment and new and innovative
ways for this investment to reach the people who most need it.
We did not micromanage the process and we did not
create unnecessary work for national authorities. Instead, we used
best practices within the specifics of country situations.
We broke new ground and pioneered new principles.
Last year we invited the 74 poorest countries to
submit proposals to the GAVI Secretariat. Before the end of last year
financial support started to flow and vaccines started to reach
countries at the turn of the year. To date 54 countries have
responded, 36 countries have been approved and the fund has made
commitments amounting to US$ 600 million dollars over the
next five years.
What has made GAVI’s success possible?
GAVI and the Vaccine Fund had one exceptional early
commitment of funding of US$ 750 million from the Bill and Melinda
Gates Foundation.
This commitment turned a fledgling initiative into
a serious player. The early confidence and commitment of the Gates
family was a catalyst for additional support from the Governments of
the United Kingdom, Norway, the Netherlands, the United States and
others.
A firm substantial multi-year commitment gave GAVI
the freedom to move quickly and streamline procedures. It enabled us
to go straight from the launch to the distribution of money for
vaccines. The longer-term perspective and commitments have stimulated
countries to undertake multi-year planning.
We resisted pressures to make the GAVI process
comprehensive, complex and laborious. We avoided high transaction
costs. And we kept decision making at the country level and recruited
locally.
GAVI is a model for new initiatives, including the
nascent Global Fund for AIDS and Health. It demonstrates that global
partnerships do not need large secretariats to administer their
activities.
Colleagues,
Of the 74 countries eligible for support from the
Vaccine Fund, 36 are in Africa. And of those 36 countries, 19
countries have already been approved for GAVI support including
Tanzania, Liberia, Madagascar, and Mozambique.
Of course, being approved for support is the first
step. Once approved, the important work is still ahead, namely
strengthening health systems so that more children will be immunized.
And since GAVI is operating under a principle of performance-based
grants, countries will have to work hard to achieve tangible results,
and document their success over time.
We have seen great success, but there are also
several challenges at the country level.
We need:
- To better utilize immunization support services.
-
To further strengthen national and
interagency co-ordination.
-
To strengthen political and social
mobilization efforts especially around the central importance of
investing in health.
-
To introduce new and underused
combination vaccines.
-
Effective operation of health systems -
even in situations of severe under-funding.
-
Effective, fast and transparent
mechanisms for moving money to where it is needed, and spending it
effectively and efficiently.
Last, but not least, we must:
- Help eligible countries that have not been approved to receive
GAVI assistance. I implore those countries to seek the help they
need so that they will be considered for this vital funding.
Your leadership is needed to take the work forward.
Together, we can reach the target of vaccinating at least 85% of all
African children.
Thank you.
|